← Fundamentals
Fundamentals · EDGAR XBRL · Real Estate

CPT

Latest: FY2025 · Thesis page →
Revenue$13.0M+83.1% YoY
Net income$384.5M+135.5% YoY
Free cash flow—YoY n/a
Gross margin—

Revenue vs Net income

Reported dollars from 10-Q / 10-K filings. Q4 bars are derived (annual less nine months) where the 10-K does not tag Q4 separately.

■ Revenue   ■ Net income
$0$235.3M$470.6M$705.9MFY21FY22FY23FY24FY25

Margin trend

Gross, operating and net margin. Margins are derived from reported dollars.

● Gross margin   ● Operating margin   ● Net margin
760%5210%9660%14110%FY21FY22FY23FY24FY25

Revenue YoY growth

Year-over-year change vs the same quarter (or fiscal year) a year earlier. Shown where the prior-year period is in the 8-quarter snapshot (latest four quarters).

-50%-33%+103%+83%FY21FY22FY23FY24FY25

Income statement

From 10-Q / 10-K XBRL. Values in reported dollars; EPS in $/share; share counts in shares.

FY21FY22FY23FY24FY25
Revenue$10.5M$5.2M$3.5M$7.1M$13.0M
YoY—-50.5%-32.7%+102.9%+83.1%
Cost of goods sold$417.0M$498.1M$548.9M$558.8M$566.7M
YoY—+19.4%+10.2%+1.8%+1.4%
Gross profit—————
YoY—————
Research & development—————
YoY—————
Selling, general & administrative—————
YoY—————
Operating income—————
YoY—————
Pretax income—————
YoY—————
Income tax—————
YoY—————
Net income$303.9M$653.6M$403.3M$163.3M$384.5M
YoY—+115.1%-38.3%-59.5%+135.5%
EPS — basic$2.97$6.07$3.71$1.50$3.54
YoY—+104.4%-38.9%-59.6%+136.0%
EPS — diluted$2.96$6.04$3.70$1.50$3.54
YoY—+104.1%-38.7%-59.5%+136.0%
Weighted shares — basic102.0M107.6M108.7M108.5M108.4M
Weighted shares — diluted102.8M108.4M109.4M108.5M108.4M

Balance sheet

Point-in-time values at each quarter (or fiscal year) end.

FY21FY22FY23FY24FY25
Cash & equivalents$613.4M$10.7M$259.7M$21.0M$25.2M
YoY—-98.3%+2327.1%-91.9%+20.0%
Marketable securities (current)—————
YoY—————
Accounts receivable—————
YoY—————
Inventory—————
YoY—————
Total current assets—————
YoY—————
Total assets$8.0B$9.3B$9.4B$8.9B$9.0B
YoY—+16.9%+0.6%-5.7%+2.2%
Total current liabilities—————
YoY—————
Total liabilities$3.7B$4.3B$4.3B$4.1B$4.6B
YoY—+15.1%+1.4%-5.2%+12.2%
Total equity$4.2B$5.0B$5.0B$4.7B$4.4B
YoY—+18.8%-0.1%-6.1%-6.7%
Shares outstanding103.3M106.5M106.8M106.7M104.3M
YoY—+3.1%+0.3%-0.1%-2.2%

Cash flow

Quarterly values derived from year-to-date filings (Q4 from the 10-K). Free cash flow = operating cash flow − capital expenditures.

FY21FY22FY23FY24FY25
Operating cash flow$577.5M$744.7M$795.0M$774.9M$826.6M
YoY—+29.0%+6.8%-2.5%+6.7%
Capital expenditures—————
YoY—————
Free cash flow—————
YoY—————
Dividends paid$343.0M$396.8M$434.9M$451.0M$460.9M
YoY—+15.7%+9.6%+3.7%+2.2%
Share repurchases—$0$0$50.0M$270.7M
YoY————+441.4%

Margins & ratios

Derived from the reported dollars above — no separate source.

FY21FY22FY23FY24FY25
Gross margin—————
Operating margin—————
Net margin2894.3%12569.2%11522.9%2300.0%2957.7%
Free cash flow margin—————
Effective tax rate—————
Current ratio—————
Total liabilities / equity0.88x0.86x0.87x0.88x1.06x

Peer comparison — latest full year

Same sector (Real Estate), sorted by revenue. All figures from the same EDGAR XBRL snapshot.

TickerRevenueRevenue YoYGross marginOperating marginNet marginFCF margin
CPT FY25 · this stock$13.0M+83.1%——2957.7%—
CBRE FY25$40.5B+13.4%—4.3%2.9%—
EQIX FY25$9.2B+5.4%—20.0%14.6%—
AMT FY20$8.0B+6.1%—35.9%—35.4%
SPG FY25$6.4B+6.7%—49.9%——
DLR FY25$6.1B+10.0%—10.8%21.4%—
O FY25$5.7B+9.1%——18.4%—
PSA FY25$4.8B+2.7%——37.0%—
CCI FY25$4.3B-4.4%—48.7%10.4%—
VICI FY25$4.0B+4.1%——69.3%—
EXR FY25$3.4B+3.7%—41.8%28.8%—

Source: SEC EDGAR XBRL company facts (10-Q / 10-K), snapshot generated 2026-11-03 for 218 tickers. Q4 values are derived as the 10-K annual less the first nine months, since Q4 is not separately tagged in company facts; cash-flow quarterly values are derived from year-to-date filings the same way. Free cash flow = operating cash flow − capital expenditures. Blank cells mean the filing does not report that line item under a standard US-GAAP tag — nothing is estimated or filled in. Descriptive research, not investment advice. How EarnIQ builds fundamentals.